Halling Cecilie, Conroy Sara, Raymond Tia, Foglia Elizabeth E, Haggerty Mary, Brown Linda L, Wyckoff Myra H
Division of Neonatology, Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University, Columbus, OH.
Center for Perinatal Research and the Ohio Perinatal Research Network, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH; Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, OH; Biostatistics Resource at Nationwide Children's Hospital, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH.
J Pediatr. 2024 Aug;271:114058. doi: 10.1016/j.jpeds.2024.114058. Epub 2024 Apr 16.
To assess whether initial epinephrine administration by endotracheal tube (ET) in newly born infants receiving chest compressions and epinephrine in the delivery room (DR) is associated with lower rates of return of spontaneous circulation (ROSC) than newborns receiving initial intravenous (IV) epinephrine.
We conducted a retrospective review of neonates receiving chest compressions and epinephrine in the DR from the AHA Get With The Guidelines-Resuscitation registry from October 2013 through July 2020. Neonates were classified according to initial route of epinephrine (ET vs IV). The primary outcome of interest was ROSC in the DR.
In total, 408 infants met inclusion criteria; of these, 281 (68.9%) received initial ET epinephrine and 127 (31.1%) received initial IV epinephrine. The initial ET epinephrine group included those infants who also received subsequent IV epinephrine when ET epinephrine failed to achieve ROSC. Comparing initial ET with initial IV epinephrine, ROSC was achieved in 70.1% vs 58.3% (adjusted risk difference 10.02; 95% CI 0.05-19.99). ROSC was achieved in 58.3% with IV epinephrine alone, and 47.0% with ET epinephrine alone, with 40.0% receiving subsequent IV epinephrine.
This study suggests that initial use of ET epinephrine is reasonable during DR resuscitation, as there were greater rates of ROSC compared with initial IV epinephrine administration. However, administration of IV epinephrine should not be delayed in those infants not responding to initial ET epinephrine, as almost one-half of infants who received initial ET epinephrine subsequently received IV epinephrine before achieving ROSC.
评估在产房(DR)接受胸外按压和肾上腺素治疗的新生儿中,经气管插管(ET)首次给予肾上腺素与接受首次静脉注射(IV)肾上腺素的新生儿相比,自主循环恢复(ROSC)率是否更低。
我们对2013年10月至2020年7月期间美国心脏协会“遵循指南-复苏”登记处中在产房接受胸外按压和肾上腺素治疗的新生儿进行了回顾性研究。新生儿根据肾上腺素的初始给药途径(ET与IV)进行分类。感兴趣的主要结局是产房内的ROSC。
共有408名婴儿符合纳入标准;其中,281名(68.9%)接受了首次ET肾上腺素治疗,127名(31.1%)接受了首次IV肾上腺素治疗。初始ET肾上腺素组包括那些在ET肾上腺素未能实现ROSC时也接受了后续IV肾上腺素治疗的婴儿。将初始ET肾上腺素与初始IV肾上腺素进行比较,ROSC实现率分别为70.1%和58.3%(调整风险差异10.02;95%置信区间0.05-19.99)。仅使用IV肾上腺素时ROSC实现率为58.3%,仅使用ET肾上腺素时为47.0%,40.0%的婴儿接受了后续IV肾上腺素治疗。
本研究表明,在产房复苏期间初始使用ET肾上腺素是合理的,因为与初始IV肾上腺素给药相比,ROSC率更高。然而,对于那些对初始ET肾上腺素无反应的婴儿,不应延迟给予IV肾上腺素,因为几乎一半接受初始ET肾上腺素治疗的婴儿在实现ROSC之前随后接受了IV肾上腺素治疗。